Skip to content

Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate

C30H47N5O8 — CID 58582829

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate
SMILESCC(C)C[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCCCNC(=O)OC(C)(C)C)Cc2ccc(cc2)OCCC[C@@H]1C(=O)NO
InChIInChI=1S/C30H47N5O8/c1-19(2)16-23-22(27(38)35-41)8-6-15-42-21-11-9-20(10-12-21)17-24(34-26(23)37)28(39)33-18-25(36)31-13-7-14-32-29(40)43-30(3,4)5/h9-12,19,22-24,41H,6-8,13-18H2,1-5H3,(H,31,36)(H,32,40)(H,33,39)(H,34,37)(H,35,38)/t22-,23+,24-/m0/s1
InChIKeyYAPPKLMBSJFRRI-VXNXHJTFSA-N
MW605.73 g/mol
LogP1.82
Rot. Bonds10

About Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate

Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate (PubChem CID 58582829) has the molecular formula C30H47N5O8 and a molecular weight of 605.73 g/mol. Its IUPAC name is tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate.

Molecular Properties

Compound NameTert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate
PubChem CID58582829
Molecular FormulaC30H47N5O8
Molecular Weight605.73 g/mol
Exact Mass605.34
IUPAC Nametert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate
SMILESCC(C)C[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCCCNC(=O)OC(C)(C)C)Cc2ccc(cc2)OCCC[C@@H]1C(=O)NO
InChIInChI=1S/C30H47N5O8/c1-19(2)16-23-22(27(38)35-41)8-6-15-42-21-11-9-20(10-12-21)17-24(34-26(23)37)28(39)33-18-25(36)31-13-7-14-32-29(40)43-30(3,4)5/h9-12,19,22-24,41H,6-8,13-18H2,1-5H3,(H,31,36)(H,32,40)(H,33,39)(H,34,37)(H,35,38)/t22-,23+,24-/m0/s1
InChIKeyYAPPKLMBSJFRRI-VXNXHJTFSA-N
XLogP1.82
TPSA184.19 Ų
H-Bond Donors6
H-Bond Acceptors8
Rotatable Bonds10
Heavy Atoms43
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500605.73
LogP ≤ 51.82
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate?
The IUPAC name of Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate (CID 58582829) is tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate.
What is the SMILES notation for Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate?
The canonical SMILES for Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate is CC(C)C[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCCCNC(=O)OC(C)(C)C)Cc2ccc(cc2)OCCC[C@@H]1C(=O)NO.
What is the InChIKey of Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate?
The InChIKey is YAPPKLMBSJFRRI-VXNXHJTFSA-N. The full InChI is InChI=1S/C30H47N5O8/c1-19(2)16-23-22(27(38)35-41)8-6-15-42-21-11-9-20(10-12-21)17-24(34-26(23)37)28(39)33-18-25(36)31-13-7-14-32-29(40)43-30(3,4)5/h9-12,19,22-24,41H,6-8,13-18H2,1-5H3,(H,31,36)(H,32,40)(H,33,39)(H,34,37)(H,35,38)/t22-,23+,24-/m0/s1.
What are the key properties of Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate?
Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate has a molecular weight of 605.73 g/mol, XLogP of 1.82, 10 rotatable bonds, 6 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for Tert-butyl N-[3-[[2-[[(6S,7R,10S)-6-(hydroxycarbamoyl)-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-10-carbonyl]amino]acetyl]amino]propyl]carbamate is sourced from PubChem (CID 58582829), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.